Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma | Zendy

Timothy F. Cloughesy | Zendy; Kevin Petrecca | Zendy; Tobias Walbert | Zendy; Nicholas Butowski | Zendy; Michael Salacz | Zendy; James Perry | Zendy; Denise Damek | Zendy; Daniela A. Bota | Zendy; Chetan Bettegowda | Zendy; JayJiguang Zhu | Zendy; Fábio M. Iwamoto | Zendy; Dimitris G. Placantonakis | Zendy; Lyndon Kim | Zendy; Brad Elder | Zendy; George Kaptain | Zendy; David Cachia | Zendy; Yaron A. Moshel | Zendy; Steven Brem | Zendy; David Piccioni | Zendy; Joseph Landolfi | Zendy; Clark C. Chen | Zendy; Harry E. Gruber | Zendy; Aliz R. Rao | Zendy; Daniel J. Hogan | Zendy; William P. Accomando | Zendy; Derek Ostertag | Zendy; Tiffany T. Montellano | Zendy; Thian Kheoh | Zendy; Fairooz F. Kabbinavar | Zendy; Michael A. Vogelbaum | Zendy

Open Access

Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma

Author(s) -

Timothy F. Cloughesy,

Kevin Petrecca,

Tobias Walbert,

Nicholas Butowski,

Michael Salacz,

James Perry,

Denise Damek,

Daniela A. Bota,

Chetan Bettegowda,

JayJiguang Zhu,

Fábio M. Iwamoto,

Dimitris G. Placantonakis,

Lyndon Kim,

Brad Elder,

George Kaptain,

David Cachia,

Yaron A. Moshel,

Steven Brem,

David Piccioni,

Joseph Landolfi,

Clark C. Chen,

Harry E. Gruber,

Aliz R. Rao,

Daniel J. Hogan,

William P. Accomando,

Derek Ostertag,

Tiffany T. Montellano,

Thian Kheoh,

Fairooz F. Kabbinavar,

Michael A. Vogelbaum

Publication year - 2020

Publication title -

jama oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 8.846

H-Index - 99

eISSN - 2374-2445

pISSN - 2374-2437

DOI - 10.1001/jamaoncol.2020.3161

Subject(s) - medicine , glioma , flucytosine , oncology , resection , standard of care , surgery , cancer research , dermatology , fluconazole , antifungal

New treatments are needed to improve the prognosis of patients with recurrent high-grade glioma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog